DK130836B - Fremgangsmåde til fremstilling af 3-hydroxy-9alfa-hydrogen-11-hydroxyring A-aromatiske steroider. - Google Patents

Fremgangsmåde til fremstilling af 3-hydroxy-9alfa-hydrogen-11-hydroxyring A-aromatiske steroider.

Info

Publication number
DK130836B
DK130836B DK524771A DK524771A DK130836B DK 130836 B DK130836 B DK 130836B DK 524771 A DK524771 A DK 524771A DK 524771 A DK524771 A DK 524771A DK 130836 B DK130836 B DK 130836B
Authority
DK
Denmark
Prior art keywords
hydroxy
9alpha
hydrogen
preparation
ring
Prior art date
Application number
DK524771A
Other languages
Danish (da)
English (en)
Other versions
DK130836C (enExample
Inventor
G H Phillipps
J P Turnbull
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK130836B publication Critical patent/DK130836B/da
Application granted granted Critical
Publication of DK130836C publication Critical patent/DK130836C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DK524771A 1970-10-30 1971-10-28 Fremgangsmåde til fremstilling af 3-hydroxy-9alfa-hydrogen-11-hydroxyring A-aromatiske steroider. DK130836B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5179270 1970-10-30

Publications (2)

Publication Number Publication Date
DK130836B true DK130836B (da) 1975-04-21
DK130836C DK130836C (enExample) 1975-11-03

Family

ID=10461392

Family Applications (1)

Application Number Title Priority Date Filing Date
DK524771A DK130836B (da) 1970-10-30 1971-10-28 Fremgangsmåde til fremstilling af 3-hydroxy-9alfa-hydrogen-11-hydroxyring A-aromatiske steroider.

Country Status (5)

Country Link
DE (1) DE2154050A1 (enExample)
DK (1) DK130836B (enExample)
FR (1) FR2113243A5 (enExample)
GB (1) GB1353598A (enExample)
NL (1) NL7114743A (enExample)

Also Published As

Publication number Publication date
NL7114743A (enExample) 1972-05-03
DE2154050A1 (de) 1972-05-04
GB1353598A (en) 1974-05-22
DK130836C (enExample) 1975-11-03
FR2113243A5 (enExample) 1972-06-23

Similar Documents

Publication Publication Date Title
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK136218B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxysteroider af pregnan- eller 19-norpregnanrækken.
DK139576B (da) Fremgangsmåde til isolering af alfa-6-desoxy-5-oxytetracyklin.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK128895B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
DK130957B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK126998B (da) Analogifremgangsmåde til fremstilling af amino-s-triazolylbenzensulfonamidforbindelser.
DK131296B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-19-nor-5alfa-pregnan-11,20-dion.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK137181B (da) Analogifremgangsmåde til fremstilling af 3-amino-kinolinderivater.
DK131786B (da) Fremgangsmåde til fremstilling af delta4-3-oxo-1alfa-methylsteroider.
DK138021B (da) Fremgangsmåde til fremstilling af aminopenicilliner.
DK135425B (da) Analogifremgangsmåde til fremstilling af 2-imidazolidonderivater.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK129450B (da) Fremgangsmåde til ætinylering af 17-ketosteroider.
DK137860B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepin-5N-oxydderivater.
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK127107B (da) Fremgangsmåde til fremstilling af 17α-propadienyl-17β-hydroxy-steroider.
DK129138B (da) Fremgangsmåde til fremstilling af tuberactinomycin-N.
DK127852B (da) Analogifremgangsmåde til fremstilling af 22-substituerede cardenolidrhamnosider.
DK127414B (da) Analogifremgangsmåde til fremstilling af phenylhydrazider.